Lewis v. Lead Industries Ass'n , 2018 IL App (1st) 172894 ( 2019 )


Menu:
  •                                                                                Digitally signed by
    Reporter of
    Decisions
    Reason: I attest to
    Illinois Official Reports                        the accuracy and
    integrity of this
    document
    Appellate Court                          Date: 2019.07.18
    13:32:19 -05'00'
    Lewis v. Lead Industries Ass’n, 
    2018 IL App (1st) 172894
    Appellate Court          MARY LEWIS, TASHSWAN BANKS, and KATHLEEN
    Caption                  O’SULLIVAN, Plaintiffs, v. LEAD INDUSTRIES ASSOCIATION,
    INC.; ATLANTIC RICHFIELD COMPANY; CONAGRA
    GROCERY PRODUCTS, INC.; NL INDUSTRIES, INC.; and THE
    SHERWIN-WILLIAMS COMPANY, Defendants (Mary Lewis and
    Tashswan Banks, Plaintiffs-Appellants; Atlantic Richfield Company;
    ConAgra Grocery Products, Inc.; NL Industries, Inc.; and
    Sherwin-Williams Company, Defendants-Appellees).
    District & No.           First District, Fifth Division
    Docket No. 1-17-2894
    Filed                    September 7, 2018
    Decision Under           Appeal from the Circuit Court of Cook County, No. 00-CH-9800; the
    Review                   Hon. Peter Flynn, Judge, presiding.
    Judgment                 Reversed and remanded.
    Counsel on               Michael H. Moirano and Clair Gorman Kenny, of Moirano Gorman
    Appeal                   Kenny, LLC, of Chicago, for appellants.
    Andre M. Pauka, of Barlit Beck Herman Palenchar & Scott LLP, of
    Chicago, for appellees.
    Panel                     JUSTICE HOFFMAN delivered the judgment of the court, with
    opinion.
    Justices Cunningham and Connors concurred in the judgment and
    opinion.
    OPINION
    ¶1         Mary Lewis and Tashswan Banks appeal from an order of the circuit court granting
    summary judgment in favor of Atlantic Richfield Company; ConAgra Grocery Products, Inc.;
    NL Industries, Inc.; and The Sherwin-Williams Company (hereinafter collectively referred to
    as defendants). For the reasons that follow, we reverse and remand the matter back to the
    circuit court for further proceedings.
    ¶2         Lewis, Banks, and Kathleen O’Sullivan, on behalf of themselves and others similarly
    situated, maintained the instant class-action suit against the defendants, seeking to recover the
    costs of blood lead screening that their children underwent as required by the Lead Poisoning
    Prevention Act (Act) (410 ILCS 45/1 et seq. (West 2000)). As certified, the class consists of
    the parents or legal guardians of children who, between August 18, 1995, and February 19,
    2008, were between six months and six years of age and, during that age bracket, lived in zip
    codes identified by the Illinois Department of Public Health as “high risk” areas pursuant to
    section 6.2(a) of the Act (410 ILCS 45/6.2(a) (West 2000)) and had a venous or capillary blood
    test for lead toxicity. Excluded from the class were parents and legal guardians who incurred
    no expense, obligation, or liability for the lead toxicity testing of their children.
    ¶3         On October 6, 2016, the defendants filed a motion for summary judgment against Lewis,
    Banks, and O’Sullivan, contending that none of the three incurred any expense, obligation, or
    liability for the lead toxicity testing of their children. Supported by the deposition testimony of
    Lewis and Banks, the defendants asserted that both were Medicaid recipients when their
    children were tested and neither paid for those tests. As to O’Sullivan, the defendants
    supported the motion with her deposition, establishing that her family was insured by Blue
    Cross Blue Shield and that she had no recollection of paying for blood testing of her children.
    ¶4         On April 20, 2017, the circuit court entered a memorandum order, granting the defendants’
    motion for summary judgment against Lewis, Banks, and O’Sullivan. The circuit court found
    that neither Lewis nor Banks is a member of the class previously certified, as neither incurred
    any expense, obligation, or liability for the lead toxicity testing of their children. As to
    O’Sullivan, the circuit court found that she failed to show that she was a member of the
    certified class by reason of her failure to present facts tending to show that she incurred an
    expense, obligation, or liability for the testing of her children. On October 19, 2017, the circuit
    court entered a written order finding that there is no just reason to delay enforcement of, or
    appeal from, the summary judgment entered against Lewis and Banks on April 20, 2017. It
    declined, however, to make similar findings as to the summary judgment entered against
    O’Sullivan.
    ¶5         On November 6, 2017, Lewis and Banks filed their notice of appeal from the summary
    judgment entered against them, invoking this court’s jurisdiction pursuant to Illinois Supreme
    Court Rule 304(a) (eff. Mar. 8, 2016). O’Sullivan is not a party to this appeal.
    -2-
    ¶6         As this matter comes to us on appeal from an order granting summary judgment, our
    review is de novo. In re Estate of Hoover, 
    155 Ill. 2d 402
    , 411 (1993). Summary judgment is
    appropriate “if the pleadings, depositions, and admissions on file, together with the affidavits,
    if any, show that there is no genuine issue as to any material fact and the moving party is
    entitled to a judgment as a matter of law.” 735 ILCS 5/2-1005(c) (West 2016).
    ¶7         The facts relevant to the disposition of this appeal are not in dispute. Both Lewis and Banks
    were Medicaid recipients when their children were tested for lead toxicity, the cost of the
    testing was paid by Medicaid, and neither paid any portion of the testing costs. In their reply
    brief, Lewis and Banks admit that, to be members of the plaintiff class, they “must establish
    that they incurred an expense, obligation, or liability” for the testing of their children. The
    issue presented is one of law: whether the parents of minor children who underwent lead
    toxicity testing that was paid for entirely by Medicaid incurred an “expense, obligation or
    liability” for the cost of the testing.
    ¶8         In urging reversal of the summary judgment entered against them, Lewis and Banks argue
    that, as parents, they were primarily responsible for the medical expenses of their minor
    children. See In the Interest of Wheat, 
    68 Ill. App. 3d 471
    , 475-76 (1979). They assert that their
    liability for the cost of the testing of their children was incurred at the time that the services
    were rendered, without regard to the fact that the cost of the testing was paid entirely by
    Medicaid on some future date. Invoking the “collateral source rule,” Lewis and Banks argue
    that their right to recovery for the reasonable value of their children’s lead toxicity testing is
    not diminished by the fact Medicaid paid the entire cost.
    ¶9         In support of the summary judgment entered in their favor, the defendants argue that,
    because the entire cost of the lead toxicity testing of their minor children was paid by
    Medicaid, Lewis and Banks did not incur any expense, obligation, or liability for the testing.
    The defendants predicate their argument in this regard on the fact that a service provider
    eligible to receive payments under Medicaid may not charge any individual for services that
    the individual is entitled to have payment made through Medicaid (see 42 U.S.C.
    § 1395cc(a)(1)(A)(i) (2012); 89 Ill. Adm. Code 140.12(i)(1) (2014)), and the State may not
    seek reimbursement from a Medicaid recipient for any payments made to health care providers
    for services rendered on their behalf (see 42 U.S.C. § 1396p(b)(1) (2012)). They contend that
    the statutes governing Medicaid: “(i) completely insulate plaintiffs [Lewis and Banks] from
    any obligation to pay the providers, and (ii) impose no obligation on plaintiffs [Lewis and
    Banks] to reimburse the State.” Although we agree that neither Lewis nor Banks is obligated to
    reimburse the State for all, or any portion, of the payment made for the testing of their children,
    we disagree that their eligibility for Medicaid payments insulated them from any obligation to
    pay for the testing services.
    ¶ 10       “[T]he Family Expense Act [(750 ILCS 65/15 (West 2000))] codifies the common-law rule
    making parents liable for the expenses of their minor children.” Manago v. County of Cook,
    
    2017 IL 121078
    , ¶ 12 (citing Clark v. Children’s Memorial Hospital, 
    2011 IL 108656
    , ¶ 51).
    That statute obligates parents to pay for the “expenses of the family,” which includes
    medical expenses of their minor children. 750 ILCS 65/15(a)(1) (West 2000); Graul v.
    Adrian, 
    32 Ill. 2d 345
    , 347 (1965); Pirrello v. Maryville Academy, Inc., 
    2014 IL App (1st) 133964
    , ¶ 11. The obligation to pay the medical expenses for a minor child is that of the parent,
    and, therefore, the cause of action to recover for medical expenses lies in the parent. Estate of
    Hammond v. Aetna Casualty, 
    141 Ill. App. 3d 963
    , 965 (1986). The parent’s right of action is
    -3-
    not affected by the fact that a third party paid those expenses. 
    Id. And the
    fact that the source of
    the payment was Medicaid, as opposed to a private insurance company, is a “distinction
    without a difference.” See Wills v. Foster, 
    229 Ill. 2d 393
    , 418 (2008).
    ¶ 11        The collateral source rule provides that benefits received by an injured party from a source
    wholly independent of, and collateral to, the tortfeasor will not diminish the damages that are
    recoverable from the tortfeasor. See 
    id. at 399.
    The defendants do not deny that the payments
    by Medicaid for the lead toxicity testing of Lewis’s and Banks’s minor children was
    independent of, and collateral to, them. The defendants contend, however, that the collateral
    source rule does not apply in a case involving a purely economic injury. We disagree.
    ¶ 12        One of the justifications for the collateral source rule is that a tortfeasor should not benefit
    from, or take advantage of, the contracts or other relations that may exist between an injured
    party and third persons. Wilson v. The Hoffman Group, Inc., 
    131 Ill. 2d 308
    , 320 (1989). That
    justification is no less compelling in a case involving a purely economic injury than in a case
    involving personal injury. In either case, a “ ‘benefit that is directed to the injured party should
    not be shifted so as to become a windfall for the tortfeasor.’ ” Arthur v. Catour, 
    216 Ill. 2d 72
    ,
    78-79 (2005) (quoting Restatement (Second) of Torts § 920A(2), Comment b, at 514 (1979)).
    And it matters little that the benefit bestowed upon the injured party is the result of a
    relationship with the government such as her entitlement to Medicaid benefits. See 
    Willis, 229 Ill. 2d at 413
    .
    ¶ 13        Lewis and Banks seek recovery for the cost of the lead toxicity testing of their minor
    children that they allege was the proximate result of the defendants’ civil conspiracy. As
    parents, they were statutorily liable for the cost of that testing. We conclude, therefore, that
    they have a cause of action for the reasonable value of the testing services, without regard to
    the fact that Medicaid paid the entire cost.
    ¶ 14        Based on the foregoing analysis, we reverse the summary judgment entered against Lewis
    and Banks on April 20, 2017, and remand this cause to the circuit court for further proceedings.
    ¶ 15       Reversed and remanded.
    -4-